“Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress GlobeNewswire•
The Geron Website also has slides from the Imetelstat Oral Presentation, “Imetelstat in RBC Transfusion-Dependent (TD) Lower Risk MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge): Updated Efficacy and Safety” by “Fenaux P, et al. EHA 2018” (https://www.geron.com/file.cfm/53/docs/Imetelstat-IMergePart1-EHA-2018.pdf; obtained on 6-18-2018).
The Author is a shareholder of Geron.
The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.